News
Hosted on MSN9mon
Takeda Pharmaceutical Company Limited (TAK): A Cheap Pharmaceutical Stock to Buy According to Short SellersIn this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other cheap pharmaceutical stocks. The pharmaceutical industry is one of ...
Hosted on MSN3mon
Is Takeda Pharmaceutical Company Limited (TAK) the Best Low Price Pharma Stock to Invest In Right Now?In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other pharma stocks. Healthcare, which includes numerous businesses that ...
We have seen 140 institutional investors add shares of TAK stock to their portfolio, and 133 decrease their positions in their most recent quarter. Here are some of the largest recent moves: Wall ...
Bhambi worked as senior level employee in the technology operations group of Takeda Pharmaceutical Company Limited. She and an alleged co-conspirator, who did not work at the company, were charged ...
Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it’s been conducting this year, bringing the total to nearly ...
May 14, 2025--Takeda (TSE: 4502/NYSE ... in objective and subjective measures of (Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said ...
Takeda, the largest pharmaceutical company by headcount in Massachusetts, with more than 5,700 employees, notified the state Executive Office of Labor and Workforce Development on Friday that it ...
Takeda Pharmaceutical Company Limited showed signs of improvement despite revenue declines in oncology and neurosciences, thanks to gains in gastrointestinal and inflammation sectors and strategic ...
US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the ...
More phase III data coursed through the annual American Society of Clinical Oncology (ASCO) conference on Sunday, as ...
The lawsuit obtained by MySA revealed that the retailers are accusing the pharmaceutical companies of conspiring to delay the release of the generic version of Takeda's heartburn medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results